{"id":"4a904e2f-4128-426e-b05e-963d96c80a3e","kind":"companies","code":"UB-C4980","name":"Quanzhentong","nameBasis":"transliterated","summary":"Quanzhen AI is a large-language-model-based AI physician assistant that lets doctors focus more on patients than medical paperwork","description":"Hangzhou Quanzhen Medical Technology developed an AI physician assistant based on large language models, described as a pioneering medical AI product in China. Combining natural language processing, image recognition, speech recognition and large models, it uses AI conversations for triage and preliminary assessment before consultations. During consultations, it helps doctors automatically generate medical records and analyze symptoms and medical histories, offering intelligent diagnostic support to help reduce missed diagnoses and misdiagnoses and improve diagnostic accuracy and efficiency. After consultations, it automates tedious tasks such as patient follow-up, reducing doctors’ workload and improving efficiency and care quality. It also offers personalized care suggestions based on individual differences and needs, aiming to improve the patient experience and rapidly increase trust in hospitals and satisfaction with services.","country":"China","category":null,"originalName":"全诊通","eventDate":null,"website":"http://www.aioclinic.com/","sourceUpdatedAt":"2026-10-05T00:00:00.000Z","englishUpdatedAt":"2026-10-20T18:23:30.119Z","reviewedAt":"2026-10-20T18:23:30.119Z","snapshotAt":"2026-10-20T18:05:01.520Z","sourceHash":"1faaac56ef08adffa9f01ded32469a8edbf9ba5e823c50324034381a64156627","companyId":null,"foundedYear":null,"logoUrl":null,"originalText":"全诊AI-基于大语言模型的AI医生助理，让医生更专注患者，而不是病历文书。\n\n杭州全诊医学科技有限公司研发的基于大语言模型的AI医生助理（简称AI医助）产品是目前国内首创的医疗人工智能产品，产品通过自然语言处理、图像识别、语音识别结合大模型技术，可以通过AI对话在诊前做到导诊和预诊，在诊中可以辅助医生自动生成病历，自动分析患者症状和病史，为医生提供智能化的辅助诊断建议，有助于减少漏诊和误诊的风险，提高诊断的准确性和效率。 AI医助产品在诊后能自动化处理一些繁琐的任务，如患者随访，减轻医生的工作负担，提高工作效率和医疗服务质量。产品还能够根据患者的个体差异和需求，提供个性化的医疗服务建议，这将对患者的就医体验带来显著提高，快速增加患者对医院的信任度和服务的满意度。","sources":[],"related":[{"id":"1ce11002-6493-44bf-88f8-9292e262ec2d","kind":"institutions","code":"UB-I3573","name":"Innovation Medical","nameBasis":"transliterated","summary":"Chuangxin Medical Management Co., Ltd.","description":"Chuangxin Medical Management Co., Ltd.","country":null,"category":null,"originalName":"创新医疗","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:06:26.226Z","englishUpdatedAt":"2026-10-15T19:36:23.456Z","reviewedAt":"2026-10-15T19:36:23.456Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"835a96e376efd0fd1902671f23fd95945514528d132a2afc3b16006912f3f3d8","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/innovation-medical"},{"id":"8642cefc-f4ed-48ad-ad55-757efb84ef7a","kind":"news","code":"8642cefc-f4ed-48ad-ad55-757efb84ef7a","name":"Quanzhentong raises RMB 27.94 million in strategic financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"全诊通完成2794万元战略投资融资","eventDate":"2024-08-28T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-14T10:58:15.532Z","englishUpdatedAt":"2026-10-15T18:29:25.526Z","reviewedAt":"2026-10-15T18:29:25.526Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"b81246d5e4d111c6a0f9dd0b45829e253ed263050818910e68ffcf17d9c4612b","companyId":"4a904e2f-4128-426e-b05e-963d96c80a3e","foundedYear":null,"logoUrl":null,"path":"/news/8642cefc-f4ed-48ad-ad55-757efb84ef7a"},{"id":"a85d6574-4529-4c5f-9c07-d938ead7e263","kind":"news","code":"a85d6574-4529-4c5f-9c07-d938ead7e263","name":"Quanzhentong raises RMB 30.8318 million in Series B financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"全诊通完成3083.18万元B轮融资","eventDate":"2025-07-02T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-14T11:08:22.331Z","englishUpdatedAt":"2026-10-15T18:29:25.596Z","reviewedAt":"2026-10-15T18:29:25.596Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"791d622430bb8a2f4a2eb4fc7557babfa731eb816d3c32e4ca192836eef84c8f","companyId":"4a904e2f-4128-426e-b05e-963d96c80a3e","foundedYear":null,"logoUrl":null,"path":"/news/a85d6574-4529-4c5f-9c07-d938ead7e263"},{"id":"28565391-da15-430f-8585-216985a4bcfa","kind":"institutions","code":"UB-I4290","name":"佳能达投资","nameBasis":"transliterated","summary":"Jianengda Investment is a Chinese venture capital firm, specializing in equity investment in seed-, startup- and growth-stage technology startups.","description":"Jianengda Investment is a Chinese venture capital firm, specializing in equity investment in seed-, startup- and growth-stage technology startups.","country":null,"category":null,"originalName":"佳能达投资","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:04:26.261Z","englishUpdatedAt":"2026-10-15T18:26:24.760Z","reviewedAt":"2026-10-15T18:26:24.760Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"f108fb478aac0a7e22b7d2370385e3ff5d3ab2b04b1fd91f7e4ccdebbde7018e","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Jianengda Investment","path":"/institutions/jianengda-investment"}],"finance":{"funding":{"metric":"funding","count":2,"latest":{"value":4404543,"text":"3083.18万元","date":"2025-07-02T00:00:00.000Z","round":"Series B","estimate":"RMB 30.8M"},"years":[2024,2025],"points":[{"year":2024,"date":"2024-08-28T00:00:00.000Z","round":"Strategic","value":3991429,"eventIds":["8642cefc-f4ed-48ad-ad55-757efb84ef7a"]},{"year":2025,"date":"2025-07-02T00:00:00.000Z","round":"Series B","value":4404543,"eventIds":["a85d6574-4529-4c5f-9c07-d938ead7e263"]}],"linePoints":[],"conflictGroups":0,"omittedRecordCount":0,"records":[{"id":"a85d6574-4529-4c5f-9c07-d938ead7e263","date":"2025-07-02T00:00:00.000Z","round":"Series B","amountText":"3083.18万元","estimateUsd":4404543,"estimateLabel":"RMB 30.8M","estimateNote":"≈ $4.4M","investors":"佳能达投资","institutions":[{"id":"28565391-da15-430f-8585-216985a4bcfa","kind":"institutions","code":"UB-I4290","name":"佳能达投资","nameBasis":"transliterated","summary":"Jianengda Investment is a Chinese venture capital firm, specializing in equity investment in seed-, startup- and growth-stage technology startups.","description":"Jianengda Investment is a Chinese venture capital firm, specializing in equity investment in seed-, startup- and growth-stage technology startups.","country":null,"category":null,"originalName":"佳能达投资","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:04:26.261Z","englishUpdatedAt":"2026-10-15T18:26:24.760Z","reviewedAt":"2026-10-15T18:26:24.760Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"f108fb478aac0a7e22b7d2370385e3ff5d3ab2b04b1fd91f7e4ccdebbde7018e","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Jianengda Investment","path":"/institutions/jianengda-investment"}],"newsUrl":null,"evidence":{"headline":"Quanzhentong raises RMB 30.8318 million in Series B financing","brief":null,"basis":null,"newsPath":"/news/a85d6574-4529-4c5f-9c07-d938ead7e263","sourceCount":0}},{"id":"8642cefc-f4ed-48ad-ad55-757efb84ef7a","date":"2024-08-28T00:00:00.000Z","round":"Strategic","amountText":"2794万元","estimateUsd":3991429,"estimateLabel":"RMB 27.9M","estimateNote":"≈ $3.99M","investors":"创新医疗(002173)","institutions":[{"id":"1ce11002-6493-44bf-88f8-9292e262ec2d","kind":"institutions","code":"UB-I3573","name":"Innovation Medical","nameBasis":"transliterated","summary":"Chuangxin Medical Management Co., Ltd.","description":"Chuangxin Medical Management Co., Ltd.","country":null,"category":null,"originalName":"创新医疗","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:06:26.226Z","englishUpdatedAt":"2026-10-15T19:36:23.456Z","reviewedAt":"2026-10-15T19:36:23.456Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"835a96e376efd0fd1902671f23fd95945514528d132a2afc3b16006912f3f3d8","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/innovation-medical"}],"newsUrl":null,"evidence":{"headline":"Quanzhentong raises RMB 27.94 million in strategic financing","brief":null,"basis":null,"newsPath":"/news/8642cefc-f4ed-48ad-ad55-757efb84ef7a","sourceCount":0}}],"totalRaised":null},"valuation":{"metric":"valuation","count":2,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":2,"records":[{"id":"a85d6574-4529-4c5f-9c07-d938ead7e263","date":"2025-07-02T00:00:00.000Z","round":"Series B","amountText":null,"estimateUsd":null,"estimateLabel":null,"estimateNote":null,"investors":"佳能达投资","institutions":[{"id":"28565391-da15-430f-8585-216985a4bcfa","kind":"institutions","code":"UB-I4290","name":"佳能达投资","nameBasis":"transliterated","summary":"Jianengda Investment is a Chinese venture capital firm, specializing in equity investment in seed-, startup- and growth-stage technology startups.","description":"Jianengda Investment is a Chinese venture capital firm, specializing in equity investment in seed-, startup- and growth-stage technology startups.","country":null,"category":null,"originalName":"佳能达投资","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:04:26.261Z","englishUpdatedAt":"2026-10-15T18:26:24.760Z","reviewedAt":"2026-10-15T18:26:24.760Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"f108fb478aac0a7e22b7d2370385e3ff5d3ab2b04b1fd91f7e4ccdebbde7018e","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Jianengda Investment","path":"/institutions/jianengda-investment"}],"newsUrl":null,"evidence":{"headline":"Quanzhentong raises RMB 30.8318 million in Series B financing","brief":null,"basis":null,"newsPath":"/news/a85d6574-4529-4c5f-9c07-d938ead7e263","sourceCount":0}},{"id":"8642cefc-f4ed-48ad-ad55-757efb84ef7a","date":"2024-08-28T00:00:00.000Z","round":"Strategic","amountText":null,"estimateUsd":null,"estimateLabel":null,"estimateNote":null,"investors":"创新医疗(002173)","institutions":[{"id":"1ce11002-6493-44bf-88f8-9292e262ec2d","kind":"institutions","code":"UB-I3573","name":"Innovation Medical","nameBasis":"transliterated","summary":"Chuangxin Medical Management Co., Ltd.","description":"Chuangxin Medical Management Co., Ltd.","country":null,"category":null,"originalName":"创新医疗","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:06:26.226Z","englishUpdatedAt":"2026-10-15T19:36:23.456Z","reviewedAt":"2026-10-15T19:36:23.456Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"835a96e376efd0fd1902671f23fd95945514528d132a2afc3b16006912f3f3d8","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/innovation-medical"}],"newsUrl":null,"evidence":{"headline":"Quanzhentong raises RMB 27.94 million in strategic financing","brief":null,"basis":null,"newsPath":"/news/8642cefc-f4ed-48ad-ad55-757efb84ef7a","sourceCount":0}}]},"revenue":{"metric":"revenue","count":0,"latest":null,"years":[],"points":[],"linePoints":[],"conflictGroups":0,"omittedRecordCount":0,"records":[]}},"events":[{"id":"a85d6574-4529-4c5f-9c07-d938ead7e263","kind":"funding","eventDate":"2025-07-02T00:00:00.000Z","revenueDate":null,"round":"B轮","amountText":"3083.18万元","valuationText":null,"revenueText":"","cumulativeFundingText":"","amountEstimateUsd":4404543,"valuationEstimateUsd":null,"revenueEstimateUsd":null,"cumulativeFundingEstimateUsd":null,"investors":"佳能达投资","newsUrl":null,"newsTypes":["融资"],"institutions":[{"id":"28565391-da15-430f-8585-216985a4bcfa","kind":"institutions","code":"UB-I4290","name":"佳能达投资","nameBasis":"transliterated","summary":"Jianengda Investment is a Chinese venture capital firm, specializing in equity investment in seed-, startup- and growth-stage technology startups.","description":"Jianengda Investment is a Chinese venture capital firm, specializing in equity investment in seed-, startup- and growth-stage technology startups.","country":null,"category":null,"originalName":"佳能达投资","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:04:26.261Z","englishUpdatedAt":"2026-10-15T18:26:24.760Z","reviewedAt":"2026-10-15T18:26:24.760Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"f108fb478aac0a7e22b7d2370385e3ff5d3ab2b04b1fd91f7e4ccdebbde7018e","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Jianengda Investment","path":"/institutions/jianengda-investment"}],"roundName":"Series B","amountLabel":"RMB 30.8M","valuationLabel":null,"revenueLabel":null,"cumulativeFundingLabel":null},{"id":"8642cefc-f4ed-48ad-ad55-757efb84ef7a","kind":"funding","eventDate":"2024-08-28T00:00:00.000Z","revenueDate":null,"round":"战略投资","amountText":"2794万元","valuationText":null,"revenueText":"","cumulativeFundingText":"","amountEstimateUsd":3991429,"valuationEstimateUsd":null,"revenueEstimateUsd":null,"cumulativeFundingEstimateUsd":null,"investors":"创新医疗(002173)","newsUrl":null,"newsTypes":["融资"],"institutions":[{"id":"1ce11002-6493-44bf-88f8-9292e262ec2d","kind":"institutions","code":"UB-I3573","name":"Innovation Medical","nameBasis":"transliterated","summary":"Chuangxin Medical Management Co., Ltd.","description":"Chuangxin Medical Management Co., Ltd.","country":null,"category":null,"originalName":"创新医疗","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:06:26.226Z","englishUpdatedAt":"2026-10-15T19:36:23.456Z","reviewedAt":"2026-10-15T19:36:23.456Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"835a96e376efd0fd1902671f23fd95945514528d132a2afc3b16006912f3f3d8","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/innovation-medical"}],"roundName":"Strategic","amountLabel":"RMB 27.9M","valuationLabel":null,"revenueLabel":null,"cumulativeFundingLabel":null}],"team":[],"productsRelated":[],"investors":[{"id":"1ce11002-6493-44bf-88f8-9292e262ec2d","kind":"institutions","code":"UB-I3573","name":"Innovation Medical","nameBasis":"transliterated","summary":"Chuangxin Medical Management Co., Ltd.","description":"Chuangxin Medical Management Co., Ltd.","country":null,"category":null,"originalName":"创新医疗","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:06:26.226Z","englishUpdatedAt":"2026-10-15T19:36:23.456Z","reviewedAt":"2026-10-15T19:36:23.456Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"835a96e376efd0fd1902671f23fd95945514528d132a2afc3b16006912f3f3d8","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/innovation-medical"},{"id":"28565391-da15-430f-8585-216985a4bcfa","kind":"institutions","code":"UB-I4290","name":"佳能达投资","nameBasis":"transliterated","summary":"Jianengda Investment is a Chinese venture capital firm, specializing in equity investment in seed-, startup- and growth-stage technology startups.","description":"Jianengda Investment is a Chinese venture capital firm, specializing in equity investment in seed-, startup- and growth-stage technology startups.","country":null,"category":null,"originalName":"佳能达投资","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T12:04:26.261Z","englishUpdatedAt":"2026-10-15T18:26:24.760Z","reviewedAt":"2026-10-15T18:26:24.760Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"f108fb478aac0a7e22b7d2370385e3ff5d3ab2b04b1fd91f7e4ccdebbde7018e","companyId":null,"foundedYear":null,"logoUrl":null,"nameLang":"zh","transliteratedName":"Jianengda Investment","path":"/institutions/jianengda-investment"}],"path":"/companies/quan-zhen-tong","structured":{"city":"Hangzhou","country":"China","location":null,"role":null,"category":null,"company":null},"definition":"Quanzhentong is a company headquartered in Hangzhou, China.","summaryBasis":"translated","thin":false,"canonical":"https://uniquebase.ai/companies/quan-zhen-tong"}